| 1. | | Completed | Altretamine and Etoposide in Treating Patients With HIV-Related Cancer
Conditions: epidemic Kaposi's sarcoma; recurrent Kaposi's sarcoma; AIDS-related peripheral/systemic lymphoma |
| 2. | | No longer recruiting | Anhydrovinblastine in Treating Patients With Advanced Recurrent Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 3. | | Recruiting | Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
Conditions: adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 4. | | No longer recruiting | BAY 59-8862 in Treating Patients With Non-Small Cell Lung Cancer
Condition: recurrent non-small cell lung cancer |
| 5. | | Completed | BCG Plus Interferon alfa 2b in Treating Patients With Bladder Cancer
Conditions: transitional cell carcinoma of the bladder; stage I bladder cancer; recurrent bladder cancer; Quality of Life |
| 6. | | Recruiting | Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate
Conditions: adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer |
| 7. | | Recruiting | Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy
Conditions: adenocarcinoma of the prostate; recurrent prostate cancer |
| 8. | | Recruiting | Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 9. | | Recruiting | Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer
Conditions: recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer |
| 10. | | No longer recruiting | Chemotherapy and Stem Cell Transplantation in Treating Children with Central Nervous System Cancer
Conditions: central nervous system cancer; childhood brain tumor; hematopoietic and lymphoid cancer; Neuroblastoma; Retinoblastoma |
| 11. | | No longer recruiting | Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer
Conditions: Leukemia; Lymphoma |
| 12. | | No longer recruiting | Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
Conditions: Lymphoma; Leukemia; Multiple Myeloma |
| 13. | | No longer recruiting | Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
Conditions: Leukemia; Lymphoma |
| 14. | | Recruiting | Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Aplastic Anemia or Hematologic Cancer
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer |
| 15. | | Suspended | Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma
Conditions: stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma |
| 16. | | No longer recruiting | Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Conditions: recurrent adult acute myeloid leukemia; recurrent childhood acute myeloid leukemia; recurrent adult acute lymphoblastic leukemia; ... |
| 17. | | Recruiting | Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal Tract
Condition: Graft Versus Host Disease |
| 18. | | Completed | Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer
Conditions: stage III rectal cancer; Stage IV rectal cancer; stage I rectal cancer; stage I colon cancer; stage II colon cancer; liver metastases; ... |
| 19. | | Completed | Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel
Conditions: female reproductive cancer; Head and Neck Cancer; neurotoxicity; thorax and respiratory cancer |
| 20. | | Recruiting | Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 21. | | No longer recruiting | Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; myelodysplastic and myeloproliferative diseases |
| 22. | | No longer recruiting | Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Conditions: recurrent adult primary liver cancer; adult primary hepatocellular carcinoma; localized unresectable adult primary liver cancer |
| 23. | | Completed | Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma
Conditions: epidemic Kaposi's sarcoma; childhood skin cancer |
| 24. | | No longer recruiting | Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomy
Conditions: Pain; Prostate Cancer |
| 25. | | Recruiting | Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib Mesylate
Conditions: chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia |
| 26. | | Completed | Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
Conditions: AIDS-related diffuse small cleaved cell lymphoma; AIDS-related small noncleaved cell lymphoma; AIDS-related lymphoblastic lymphoma; ... |
| 27. | | No longer recruiting | Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder
Conditions: cholangiocarcinoma of the gallbladder; recurrent gallbladder cancer; unresectable gallbladder cancer; ... |
| 28. | | No longer recruiting | Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery
Conditions: stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
| 29. | | No longer recruiting | Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation
Conditions: oral complications of cancer and cancer therapy; unspecified childhood solid tumor, protocol specific |
| 30. | | No longer recruiting | High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
Conditions: adult acute myelomonocytic leukemia (M4); untreated adult acute myeloid leukemia; adult acute monocytic leukemia (M5); ... |
| 31. | | Recruiting | High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors
Condition: Cancer |
| 32. | | No longer recruiting | Interleukin-2 and Stem Cell Factor in Treating Patients With AIDS or AIDS-Related Cancer
Condition: AIDS-related peripheral/systemic lymphoma |
| 33. | | Recruiting | Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer
Conditions: recurrent breast cancer; stage IV breast cancer |
| 34. | | Recruiting | Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer
Conditions: Colon Cancer; Diarrhea; Rectal Cancer |
| 35. | | No longer recruiting | Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
Condition: Myeloid Leukemia |
| 36. | | No longer recruiting | Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 37. | | No longer recruiting | Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 38. | | No longer recruiting | Morphine for the Treatment of Pain in Patients With Breast Cancer
Condition: Pain |
| 39. | | Completed | Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer
Conditions: stage III gastric cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage II gastric cancer; stage I gastric cancer; ... |
| 40. | | No longer recruiting | Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer
Conditions: recurrent colon cancer; adenocarcinoma of the rectum; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; ... |
| 41. | | Recruiting | Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum
Conditions: adenocarcinoma of the rectum; stage III rectal cancer; stage II rectal cancer |
| 42. | | Recruiting | Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer
Conditions: Adenocarcinoma of the Esophagus; recurrent esophageal cancer; stage II esophageal cancer; stage III esophageal cancer; stage IV esophageal cancer; ... |
| 43. | | Recruiting | Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
Conditions: childhood Hodgkin's lymphoma; chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ... |
| 44. | | No longer recruiting | Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
| 45. | | No longer recruiting | Phase III Randomized Study of Cyclophosphamide with or without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients with Aplastic Anemia
Condition: Aplastic Anemia |
| 46. | | Suspended | Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer
Conditions: basal cell carcinoma of the skin; recurrent skin cancer |
| 47. | | No longer recruiting | Photodynamic Therapy in Treating Patients With Early Esophageal Cancer
Condition: stage 0 esophageal cancer |
| 48. | | Recruiting | Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia
Conditions: B-cell Chronic Lymphocytic Leukemia; stage I cutaneous T-cell lymphoma; stage I mycosis fungoides/Sezary syndrome; ... |
| 49. | | Recruiting | Photodynamic Therapy in Treating Patients With Skin Cancer
Conditions: basal cell carcinoma of the skin; squamous cell carcinoma of the skin |
| 50. | | Suspended | Photodynamic Therapy in Treating Patients With Skin Cancer
Conditions: basal cell carcinoma of the skin; squamous cell carcinoma of the skin; actinic keratosis |
